BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1512794)

  • 21. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
    Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
    BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second cancers following non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Boice JD; Hankey BF; Fraumeni JF
    Cancer; 1991 Apr; 67(7):2002-9. PubMed ID: 2004317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Tsimberidou AM; Wen S; McLaughlin P; O'Brien S; Wierda WG; Lerner S; Strom S; Freireich EJ; Medeiros LJ; Kantarjian HM; Keating MJ
    J Clin Oncol; 2009 Feb; 27(6):904-10. PubMed ID: 19114699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
    Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
    J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
    Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
    Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
    J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of second primary cancers after a diagnosis of melanoma.
    Bradford PT; Freedman DM; Goldstein AM; Tucker MA
    Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
    Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
    JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
    Zheng G; Chattopadhyay S; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
    Br J Haematol; 2019 Apr; 185(2):232-239. PubMed ID: 30706458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.
    Kaldor JM; Day NE; Band P; Choi NW; Clarke EA; Coleman MP; Hakama M; Koch M; Langmark F; Neal FE
    Int J Cancer; 1987 May; 39(5):571-85. PubMed ID: 3570550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
    Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
    Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
    Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between malignant melanoma and noncutaneous malignancies.
    Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
    Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
    J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.